FDA has proposed the development of a rating system that will help incentivize drug manufacturers to achieve Quality Mangement Maturity at their facilities.
Similar Posts
Cosmetic Manufacturers Pty Ltd. – 719225 – 02/06/2026
CGMP/Finished Pharmaceuticals/AdulteratedFDA approves drug for adult and pediatric patients aged 6 and older with allergic fungal rhinosinusitis
The U.S. Food and Drug Administration (FDA) has approved Dupixent (dupilumab) for the treatment of adult and pediatric patients aged 6 years and older with allergic fungal rhinosinusitis (AFRS) with a history of sino-nasal surgery or for whom surgery is not advisable. This is the first approval forSome Homeopathic Products May Put You at Risk
Homeopathic products are marketed without FDA review and may not meet modern standards for safety, effectiveness, quality and labeling. Learn more.FDA Drug Competition Action Plan
FDA’s Drug Competition Action Plan (DCAP) encourages robust and timely market competition for generic drugs and helps bring greater efficiency and transparency to the generic drug review process, without sacrificing the scientific rigor underlying our generic drug program.Emergency Response Safety Kit Recall: Airlife Removes Certain Broselow Pediatric Emergency Rainbow Tapes and Broselow ALS Organizers
AirLife is removing Broselow Rainbow Tapes due to incorrectly printed medication dosing information.Jewel Osco Stores in Illinois, Indiana and Iowa Voluntarily Recalls Select Items Containing Tuna Salad from Reser’s Fine Foods Due to an Ingredient Recall Linked to Possible Listeria Monocytogenes Contamination
Jewel Osco stores in Illinois, Indiana and Iowa are voluntarily recalling select items containing tuna salad supplied by Reser’s Fine Foods. This action follows a recall initiated by Reser’s Fine Food due to possible contamination with Listeria monocytogenes in breadcrumbs used as an ingredient in t